ArticleHeliyon2023
Structural analysis and characterization of date palm fiber-based low-cost carbon nanotubes and nanostructured powder activated carbon.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structural properties and characteristics of date palm fiber-based low-cost carbon nanotubes (CNTs) and nanostructured powder activated carbon (DP-NPAC) are investigated. The DP-NPAC and CNTs are prepared using an environmentally friendly method, and characterized and analyzed using field emission-scanning electron microscopy (FESEM), transmission electron microscopy (TEM), and X-ray diffraction (XRD). The results have showed that both DP-NPAC and CNTs possess crystallite structure, nano-scale, high capacity, cost-effective for multi-application that make them efficient for future fabrication and manufacturing. It is supposed that DP-NPAC biomass is to be used as potential and cost-effective precursor for synthesized CNTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.